Evaluation of the Performance and Safety of a Newly Developed Intravenous Fluid Warmer

Hee Jung Kim, Sung Mook Yoo, Ho Sung Son, Chi Bum Ahn, Yeon Soo Shin, Jae Ho Chung, Kyung Sun

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

To evaluate the performance and safety of a newly developed blood warmer (ThermoSens), we tested its heating capability under various conditions using isotonic saline and hemolysis analysis with swine blood. The following two in vitro tests were performed: (i) To investigate the performance of the device, the inflow and outflow temperatures were measured at various flow rates (30, 50, and 100mL/min) using cold (5°C) and room temperature (20°C) isotonic saline (0.9%). Several parameters were measured including the highest temperature of the outlet, the time required to reach the highest temperature, and the temperature of the intravenous line. (ii) To investigate the safety of the device, a hemolysis test was performed using swine blood. We obtained 320mL of whole blood from swine and refrigerated the blood for 35 days at 3°C. In order to replicate the clinical situation, blood flow by gravity and pressure (300mmHg) was used. Before and after the heating test, blood samples were obtained and a comparison was made between these samples. Hemoglobin, hematocrit, lactate dehydrogenase, and plasma hemoglobin were used for red blood cell (RBC) damage analysis. The highest outlet temperatures obtained using flow rates of 30, 50, and 100mL/min were 39.10±0.59, 39.25±0.69, and 37.63±1.03°C, respectively, with cold saline, and 39.40±0.40, 39.66±0.36, and 39.49±0.49°C, respectively, with room temperature saline. Hemolysis tests showed no significant changes in hemoglobin, hematocrit, lactate dehydrogenase, or plasma hemoglobin (P>0.05) between before and after heating for both gravity and pressure blood flow. The ThermoSens blood warmer warms isotonic saline effectively, reaching temperatures up to 36°C under various conditions. Hemolysis tests showed no RBC damage. Therefore, the newly developed ThermoSens has good heating performance and is safe for RBC products.

Original languageEnglish
Pages (from-to)591-596
Number of pages6
JournalArtificial Organs
Volume39
Issue number7
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Blood
Safety
Temperature
Fluids
Hemolysis
Heating
Hemoglobin
Hemoglobins
Swine
Erythrocytes
Gravitation
Hematocrit
L-Lactate Dehydrogenase
Protective Devices
Hematologic Tests
Cells
Flow rate
Plasmas
Blood pressure
Blood Pressure

Keywords

  • Blood
  • Fluid therapy
  • Heating
  • Hypothermia
  • Intravenous fluid warmer
  • Medical device

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

Evaluation of the Performance and Safety of a Newly Developed Intravenous Fluid Warmer. / Kim, Hee Jung; Yoo, Sung Mook; Son, Ho Sung; Ahn, Chi Bum; Shin, Yeon Soo; Chung, Jae Ho; Sun, Kyung.

In: Artificial Organs, Vol. 39, No. 7, 01.01.2015, p. 591-596.

Research output: Contribution to journalArticle

Kim, Hee Jung ; Yoo, Sung Mook ; Son, Ho Sung ; Ahn, Chi Bum ; Shin, Yeon Soo ; Chung, Jae Ho ; Sun, Kyung. / Evaluation of the Performance and Safety of a Newly Developed Intravenous Fluid Warmer. In: Artificial Organs. 2015 ; Vol. 39, No. 7. pp. 591-596.
@article{8344005a59a6467999ffc2fd01ed1463,
title = "Evaluation of the Performance and Safety of a Newly Developed Intravenous Fluid Warmer",
abstract = "To evaluate the performance and safety of a newly developed blood warmer (ThermoSens), we tested its heating capability under various conditions using isotonic saline and hemolysis analysis with swine blood. The following two in vitro tests were performed: (i) To investigate the performance of the device, the inflow and outflow temperatures were measured at various flow rates (30, 50, and 100mL/min) using cold (5°C) and room temperature (20°C) isotonic saline (0.9{\%}). Several parameters were measured including the highest temperature of the outlet, the time required to reach the highest temperature, and the temperature of the intravenous line. (ii) To investigate the safety of the device, a hemolysis test was performed using swine blood. We obtained 320mL of whole blood from swine and refrigerated the blood for 35 days at 3°C. In order to replicate the clinical situation, blood flow by gravity and pressure (300mmHg) was used. Before and after the heating test, blood samples were obtained and a comparison was made between these samples. Hemoglobin, hematocrit, lactate dehydrogenase, and plasma hemoglobin were used for red blood cell (RBC) damage analysis. The highest outlet temperatures obtained using flow rates of 30, 50, and 100mL/min were 39.10±0.59, 39.25±0.69, and 37.63±1.03°C, respectively, with cold saline, and 39.40±0.40, 39.66±0.36, and 39.49±0.49°C, respectively, with room temperature saline. Hemolysis tests showed no significant changes in hemoglobin, hematocrit, lactate dehydrogenase, or plasma hemoglobin (P>0.05) between before and after heating for both gravity and pressure blood flow. The ThermoSens blood warmer warms isotonic saline effectively, reaching temperatures up to 36°C under various conditions. Hemolysis tests showed no RBC damage. Therefore, the newly developed ThermoSens has good heating performance and is safe for RBC products.",
keywords = "Blood, Fluid therapy, Heating, Hypothermia, Intravenous fluid warmer, Medical device",
author = "Kim, {Hee Jung} and Yoo, {Sung Mook} and Son, {Ho Sung} and Ahn, {Chi Bum} and Shin, {Yeon Soo} and Chung, {Jae Ho} and Kyung Sun",
year = "2015",
month = "1",
day = "1",
doi = "10.1111/aor.12441",
language = "English",
volume = "39",
pages = "591--596",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Evaluation of the Performance and Safety of a Newly Developed Intravenous Fluid Warmer

AU - Kim, Hee Jung

AU - Yoo, Sung Mook

AU - Son, Ho Sung

AU - Ahn, Chi Bum

AU - Shin, Yeon Soo

AU - Chung, Jae Ho

AU - Sun, Kyung

PY - 2015/1/1

Y1 - 2015/1/1

N2 - To evaluate the performance and safety of a newly developed blood warmer (ThermoSens), we tested its heating capability under various conditions using isotonic saline and hemolysis analysis with swine blood. The following two in vitro tests were performed: (i) To investigate the performance of the device, the inflow and outflow temperatures were measured at various flow rates (30, 50, and 100mL/min) using cold (5°C) and room temperature (20°C) isotonic saline (0.9%). Several parameters were measured including the highest temperature of the outlet, the time required to reach the highest temperature, and the temperature of the intravenous line. (ii) To investigate the safety of the device, a hemolysis test was performed using swine blood. We obtained 320mL of whole blood from swine and refrigerated the blood for 35 days at 3°C. In order to replicate the clinical situation, blood flow by gravity and pressure (300mmHg) was used. Before and after the heating test, blood samples were obtained and a comparison was made between these samples. Hemoglobin, hematocrit, lactate dehydrogenase, and plasma hemoglobin were used for red blood cell (RBC) damage analysis. The highest outlet temperatures obtained using flow rates of 30, 50, and 100mL/min were 39.10±0.59, 39.25±0.69, and 37.63±1.03°C, respectively, with cold saline, and 39.40±0.40, 39.66±0.36, and 39.49±0.49°C, respectively, with room temperature saline. Hemolysis tests showed no significant changes in hemoglobin, hematocrit, lactate dehydrogenase, or plasma hemoglobin (P>0.05) between before and after heating for both gravity and pressure blood flow. The ThermoSens blood warmer warms isotonic saline effectively, reaching temperatures up to 36°C under various conditions. Hemolysis tests showed no RBC damage. Therefore, the newly developed ThermoSens has good heating performance and is safe for RBC products.

AB - To evaluate the performance and safety of a newly developed blood warmer (ThermoSens), we tested its heating capability under various conditions using isotonic saline and hemolysis analysis with swine blood. The following two in vitro tests were performed: (i) To investigate the performance of the device, the inflow and outflow temperatures were measured at various flow rates (30, 50, and 100mL/min) using cold (5°C) and room temperature (20°C) isotonic saline (0.9%). Several parameters were measured including the highest temperature of the outlet, the time required to reach the highest temperature, and the temperature of the intravenous line. (ii) To investigate the safety of the device, a hemolysis test was performed using swine blood. We obtained 320mL of whole blood from swine and refrigerated the blood for 35 days at 3°C. In order to replicate the clinical situation, blood flow by gravity and pressure (300mmHg) was used. Before and after the heating test, blood samples were obtained and a comparison was made between these samples. Hemoglobin, hematocrit, lactate dehydrogenase, and plasma hemoglobin were used for red blood cell (RBC) damage analysis. The highest outlet temperatures obtained using flow rates of 30, 50, and 100mL/min were 39.10±0.59, 39.25±0.69, and 37.63±1.03°C, respectively, with cold saline, and 39.40±0.40, 39.66±0.36, and 39.49±0.49°C, respectively, with room temperature saline. Hemolysis tests showed no significant changes in hemoglobin, hematocrit, lactate dehydrogenase, or plasma hemoglobin (P>0.05) between before and after heating for both gravity and pressure blood flow. The ThermoSens blood warmer warms isotonic saline effectively, reaching temperatures up to 36°C under various conditions. Hemolysis tests showed no RBC damage. Therefore, the newly developed ThermoSens has good heating performance and is safe for RBC products.

KW - Blood

KW - Fluid therapy

KW - Heating

KW - Hypothermia

KW - Intravenous fluid warmer

KW - Medical device

UR - http://www.scopus.com/inward/record.url?scp=84934434468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934434468&partnerID=8YFLogxK

U2 - 10.1111/aor.12441

DO - 10.1111/aor.12441

M3 - Article

C2 - 25865383

AN - SCOPUS:84934434468

VL - 39

SP - 591

EP - 596

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 7

ER -